Gentamicin B. Braun 3 mg/ ml Norge - norsk - Statens legemiddelverk

gentamicin b. braun 3 mg/ ml

b. braun melsungen ag - gentamicinsulfat - infusjonsvæske, oppløsning - 3 mg/ ml

Gentamicin B. Braun 1 mg/ ml Norge - norsk - Statens legemiddelverk

gentamicin b. braun 1 mg/ ml

b. braun melsungen ag - gentamicinsulfat - infusjonsvæske, oppløsning - 1 mg/ ml

Magnesiumsulfat B. Braun 1 mmol/ ml Norge - norsk - Statens legemiddelverk

magnesiumsulfat b. braun 1 mmol/ ml

b. braun melsungen ag - magnesiumsulfatheptahydrat - konsentrat til infusjonsvæske, oppløsning - 1 mmol/ ml

Tobramycin B. Braun 3 mg/ ml Norge - norsk - Statens legemiddelverk

tobramycin b. braun 3 mg/ ml

b. braun melsungen ag - tobramycin - infusjonsvæske, oppløsning - 3 mg/ ml

Tobramycin B. Braun 1 mg/ ml Norge - norsk - Statens legemiddelverk

tobramycin b. braun 1 mg/ ml

b. braun melsungen ag - tobramycin - infusjonsvæske, oppløsning - 1 mg/ ml

Natpar Den europeiske union - norsk - EMA (European Medicines Agency)

natpar

takeda pharmaceuticals international ag ireland branch - parathyroidhormon - hypoparathyroidisme - kalsiumhomeostase - natpar er indisert som tilleggsbehandling av voksne pasienter med kronisk hypoparathyroidisme som ikke kan kontrolleres tilstrekkelig med standard terapi alene.

Kinpeygo Den europeiske union - norsk - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, intestinal betennelsesdempende / antiinfective agents - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.

Clopidogrel Acino Den europeiske union - norsk - EMA (European Medicines Agency)

clopidogrel acino

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Metronidazole Braun 5 mg/ ml Norge - norsk - Statens legemiddelverk

metronidazole braun 5 mg/ ml

b. braun melsungen ag - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml

Nycoplus vitamin D3 800 IE Norge - norsk - Statens legemiddelverk

nycoplus vitamin d3 800 ie

stada arzneimittel ag - kolekalsiferol - kapsel, myk - 800 ie